Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Cirugía y cirujanos
On-line version ISSN 2444-054XPrint version ISSN 0009-7411
Abstract
GURROLA-MACHUCA, Héctor et al. Outcome of multidisciplinary treatment in laryngeal cancer. Retrospective study with 10-years follow-up. Cir. cir. [online]. 2020, vol.88, n.4, pp.461-466. Epub Nov 08, 2021. ISSN 2444-054X. https://doi.org/10.24875/ciru.19001540.
Background:
In laryngeal cancer, multidisciplinary treatment improves the patient’s quality of life and the possibility of preserving the larynx. Most cases occur in a locally advanced stage. The aim is to present the results according to the stage.
Method:
A retrospective study which analyzed the clinical stage, type of primary treatment, outcomes, and survival were analyzed.
Results:
451 patients were included. The median age was 66 years. The majority of the tumors presented in advanced stage (72%) and the most affected subsite was the glottis (84.5%). In the early stage the most frequent treatment was radiotherapy as the only treatment modality. In stages III and IVA, 65% were resectable. In stage IVB the management was non-surgical, with control in 26% of the cases. Survival at 10 years was related to the clinical stage: 81.7% for stage I and 0% for stages IVB and IVC.
Conclusions:
Patients with laryngeal cancer should be treated according to the clinical stage, through a multidisciplinary approach. Long-term follow-up showed a worse prognosis for advanced clinical stages.
Keywords : Larynx neoplasm; Laryngectomy; Induction chemotherapy; Chemoradiotherapy; Bioradiotherapy; Head and neck neoplasm.
